Biomarkers of liver dysfunction correlate with a prothrombotic and not with a prohaemorrhagic profile in patients with cirrhosis

Background & Aims: Different liver dysfunction biomarkers are used to assess the bleeding risk of patients with cirrhosis, either as such or included in bleeding risk assessment scores. Since the current model of coagulation in patients with cirrhosis describes a procoagulant tendency with i...

Full description

Bibliographic Details
Main Authors: Maxime G. Zermatten, Montserrat Fraga, Debora Bertaggia Calderara, Alessandro Aliotta, Darius Moradpour, Lorenzo Alberio
Format: Article
Language:English
Published: Elsevier 2020-08-01
Series:JHEP Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589555920300549